|
1
|
Church DN, Stelloo E, Nout RA, Valtcheva
N, Depreeuw J, ter Haar N, Noske A, Amant F, Tomlinson IP, Wild PJ,
et al: Prognostic significance of POLE proofreading mutations in
endometrial cancer. J Natl Cancer Inst. 107:4022014.PubMed/NCBI
|
|
2
|
Gunderson CC, Java J, Moore KN and Walker
JL: The impact of obesity on surgical staging, complications, and
survival with uterine cancer: A Gynecologic Oncology Group LAP2
ancillary data study. Gynecol Oncol. 133:23–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Medina PP and Slack FJ: microRNAs and
cancer: An overview. Cell Cycle. 7:2485–2492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Singh B, Ronghe AM, Chatterjee A, Bhat NK
and Bhat HK: MicroRNA-93 regulates NRF2 expression and is
associated with breast carcinogenesis. Carcinogenesis.
34:1165–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li F, Liu J and Li S: MicroRNA 106b
approximately 25 cluster and gastric cancer. Surg Oncol. 22:7–10.
2013. View Article : Google Scholar
|
|
7
|
Savita U and Karunagaran D:
MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression
of Snail and enhances cell migration and invasion in H1299 (non
small cell lung cancer) cells. Biochem Biophys Res Commun.
434:841–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Previs RA and Bodurka DC: Diagnosis and
management of stage II endometrial cancer. Springer; New Delhi: pp.
293–305. 2015
|
|
9
|
Hampton T: Critics of fibroid removal
procedure question risks it may pose for women with undetected
uterine cancer. JAMA. 311:891–893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hammer SM, Brown JC, Segal S, Chu CS and
Schmitz KH: Cancer-related impairments influence physical activity
in uterine cancer survivors. Med Sci Sports Exerc. 46:2195–2201.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elit LM, O'Leary EM, Pond GR and Seow HY:
Impact of wait times on survival for women with uterine cancer. J
Clin Oncol. 32:27–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Colombo N, Preti E, Landoni F, Carinelli
S, Colombo A, Marini C and Sessa C: ESMO Guidelines working group:
endometrial cancer: ESMO Clinical practice guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 24:33–38. 2013.
View Article : Google Scholar
|
|
13
|
Turchinovich A, Tonevitsky AG, Cho WC and
Burwinkel B: Check and mate to exosomal extracellular miRNA: New
lesson from a new approach. Front Mol Biosci. 2:112015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gilad S, Meiri E, Yogev Y, Benjamin S,
Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed
N, et al: Serum microRNAs are promising novel biomarkers. PLoS One.
3:e31482008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lyu X, Fang W, Cai L, Zheng H, Ye Y, Zhang
L, Li J, Peng H, Cho WC, Wang E, et al: TGFβR2 is a major target of
miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer.
13:512014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singh B, Ronghe AM, Chatterjee A, Bhat NK
and Bhat HK: MicroRNA-93 regulates NRF2 expression and is
associated with breast carcinogenesis. Carcinogenesis.
34:1165–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li F, Liang X, Chen Y, Li S and Liu J:
Role of microRNA-93 in regulation of angiogenesis. Tumour Biol.
35:10609–10613. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao ZN, Bai JX, Zhou Q, Yan B, Qin WW,
Jia LT, Meng YL, Jin BQ, Yao LB, Wang T, et al: TSA suppresses
miR-106b-93-25 cluster expression through downregulation of MYC and
inhibits proliferation and induces apoptosis in human EMC. PLoS
One. 7:e451332012. View Article : Google Scholar : PubMed/NCBI
|
